文献速递肿瘤 PET/CT骨显像与常规 SPECT

口咽癌前哨淋巴结检测中[68Ga]Ga-tilmanocept PET/CT淋巴显像与[99mTc]Tc-tilmanocept淋巴显像的患者自身对照比较:一项先导研究

Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-12-28

这项前瞻性患者自身对照先导研究在10例早期口腔癌患者中比较了[68Ga]Ga-tilmanocept PET/CT淋巴显像与[99mTc]Tc-tilmanocept淋巴显像(含SPECT/CT)的前哨淋巴结识别效果,并评估术中能否用常规便携式γ探头可靠定位。结果显示[68Ga]Ga-tilmanocept PET/CT识别更多前哨淋巴结并改善淋巴管显影,联合瘤周注射[99mTc]Tc-tilmanocept时术中γ探头可可靠定位。

要点

  • [68Ga]Ga-tilmanocept PET/CT识别33枚前哨淋巴结,其中30枚(91%)术中经常规γ探头定位。
  • [99mTc]Tc-tilmanocept淋巴显像识别24枚前哨淋巴结,除1枚外均被[68Ga]Ga-tilmanocept PET/CT识别。
  • [68Ga]Ga-tilmanocept PET/CT额外识别注射部位附近4枚前哨淋巴结,其中2枚含转移。

核心结论

  • 与[99mTc]Tc-tilmanocept淋巴显像相比,[68Ga]Ga-tilmanocept PET/CT淋巴显像能更准确地识别前哨淋巴结并改善淋巴管显影。
  • 联合瘤周注射[99mTc]Tc-tilmanocept时,[68Ga]Ga-tilmanocept PET/CT淋巴显像检出的前哨淋巴结可在术中经常规便携式γ探头可靠定位。

研究设计与样本

  • 这项前瞻性患者自身对照先导研究纳入10例计划行前哨淋巴结活检的早期口腔癌患者。
  • 患者先接受[99mTc]Tc-tilmanocept(约74 MBq)常规淋巴显像,随后瘤周注射[68Ga]Ga-tilmanocept(约10 MBq),注射后15分钟开始PET/CT采集。
  • 次日术中在常规便携式γ探头引导下定位前哨淋巴结,并将切除的前哨淋巴结位置与每例患者的两种淋巴显像图像进行关联。

主要发现

  • [99mTc]Tc-tilmanocept淋巴显像共识别24枚前哨淋巴结,除1枚外均被[68Ga]Ga-tilmanocept PET/CT淋巴显像识别。
  • [68Ga]Ga-tilmanocept PET/CT淋巴显像额外识别注射部位附近4枚前哨淋巴结,其中2枚含转移。
  • [68Ga]Ga-tilmanocept PET/CT淋巴显像在80%的患者中识别出运输[68Ga]Ga-tilmanocept的淋巴管,而[99mTc]Tc-tilmanocept淋巴显像在20%的患者中显示引流淋巴管。
  • [68Ga]Ga-tilmanocept PET/CT淋巴显像识别的33枚前哨淋巴结中,30枚(91%)在术中经常规γ探头引导定位。

关键数值与推荐

  • [99mTc]Tc-tilmanocept给药剂量约74 MBq,[68Ga]Ga-tilmanocept给药剂量约10 MBq。
  • [68Ga]Ga-tilmanocept PET/CT采集在注射后15分钟启动。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare sentinel lymph node (SLN) identification using [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy to [99mTc]Tc-tilmanocept lymphoscintigraphy (including SPECT/CT) in early-stage oral cancer. Furthermore, to assess whether reliable intraoperative SLN localization can be performed with a conventional portable gamma-probe using [99mTc]Tc-tilmanocept without the interference of [68Ga]Ga-tilmanocept in these patients. METHODS: This prospective within-patient comparison pilot study evaluated SLN identification by [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy compared to conventional lymphoscintigraphy using [99mTc]Tc-tilmanocept (~ 74 MBq) in 10 early-stage oral cancer patients scheduled for SLN biopsy. After conventional [99mTc]Tc-tilmanocept lymphoscintigraphy, patients underwent peritumoral administration of [68Ga]Ga-tilmanocept (~ 10 MBq) followed by PET/CT acquisition initiated 15 min after injection. Intraoperative SLN localization was performed under conventional portable gamma-probe guidance the next day; the location of harvested SLNs was correlated to both lymphoscintigraphic images in each patient. RESULTS: A total of 24 SLNs were identified by [99mTc]Tc-tilmanocept lymphoscintigraphy, all except one were also identified by [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy. [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy identified 4 additional SLNs near the injection site, of which two harbored metastases. Lymphatic vessels transporting [68Ga]Ga-tilmanocept were identified by PET/CT lymphoscintigraphy in 80% of patients, while draining lymphatic vessels were visualized by [99mTc]Tc-tilmanocept lymphoscintigraphy in 20% of patients. Of the 33 SLNs identified by [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy, 30 (91%) were intraoperatively localized under conventional gamma-probe guidance. CONCLUSION: [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy provided more accurate identification of SLNs and improved visualization of lymphatic vessels compared to [99mTc]Tc-tilmanocept lymphoscintigraphy. When combined with peritumoral administration of [99mTc]Tc-tilmanocept, SLNs detected by [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy can be reliably localized during surgery under conventional gamma-probe guidance.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Mahieu R, Donders DNV, Krijger GC, et al. Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2021. PMID: 34962582. doi:10.1007/s00259-021-05645-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。